Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| alpha 1-Antitrypsin | 12 | 2021 | 264 | 4.04 | Why? |
| alpha 1-Antitrypsin Deficiency | 11 | 2019 | 94 | 3.66 | Why? |
| Cystic Fibrosis | 11 | 2020 | 1104 | 2.52 | Why? |
| Trypsin Inhibitors | 2 | 2018 | 38 | 0.93 | Why? |
| Birt-Hogg-Dube Syndrome | 1 | 2019 | 6 | 0.82 | Why? |
| Acute-Phase Reaction | 1 | 2020 | 116 | 0.82 | Why? |
| Pulmonary Emphysema | 2 | 2018 | 122 | 0.81 | Why? |
| Germ-Line Mutation | 1 | 2019 | 86 | 0.77 | Why? |
| Hermanski-Pudlak Syndrome | 1 | 2018 | 5 | 0.77 | Why? |
| Codon, Nonsense | 1 | 2018 | 66 | 0.76 | Why? |
| Oxadiazoles | 1 | 2018 | 41 | 0.75 | Why? |
| Membrane Proteins | 2 | 2020 | 1733 | 0.75 | Why? |
| Furans | 1 | 2019 | 156 | 0.74 | Why? |
| Thyroid Hormones | 1 | 2020 | 213 | 0.73 | Why? |
| Expectorants | 1 | 2018 | 95 | 0.72 | Why? |
| Tumor Suppressor Proteins | 1 | 2019 | 165 | 0.72 | Why? |
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 291 | 0.70 | Why? |
| Rheumatoid Factor | 1 | 2017 | 67 | 0.68 | Why? |
| Lactic Acid | 1 | 2020 | 393 | 0.67 | Why? |
| Carrier Proteins | 1 | 2020 | 513 | 0.66 | Why? |
| Proto-Oncogene Proteins | 1 | 2019 | 340 | 0.65 | Why? |
| Interleukin-10 | 2 | 2020 | 1409 | 0.64 | Why? |
| Genotyping Techniques | 1 | 2019 | 360 | 0.64 | Why? |
| Interleukin-8 | 2 | 2020 | 964 | 0.62 | Why? |
| Antibodies, Antinuclear | 1 | 2017 | 234 | 0.59 | Why? |
| Peptides, Cyclic | 1 | 2017 | 223 | 0.59 | Why? |
| Genetic Therapy | 2 | 2018 | 409 | 0.56 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2019 | 581 | 0.55 | Why? |
| Interleukin-6 | 3 | 2021 | 7522 | 0.54 | Why? |
| Arthritis, Rheumatoid | 2 | 2017 | 2043 | 0.52 | Why? |
| Inflammasomes | 1 | 2019 | 710 | 0.49 | Why? |
| DNA | 1 | 2018 | 778 | 0.48 | Why? |
| Neutrophils | 7 | 2021 | 5476 | 0.44 | Why? |
| Sulfonamides | 1 | 2019 | 1294 | 0.43 | Why? |
| Pneumothorax | 1 | 2019 | 758 | 0.42 | Why? |
| Anti-Inflammatory Agents | 2 | 2019 | 6153 | 0.41 | Why? |
| Cystic Fibrosis Transmembrane Conductance Regulator | 3 | 2019 | 113 | 0.40 | Why? |
| Community-Acquired Infections | 2 | 2020 | 2328 | 0.38 | Why? |
| Molecular Targeted Therapy | 1 | 2018 | 1579 | 0.38 | Why? |
| Candida albicans | 1 | 2010 | 217 | 0.37 | Why? |
| Proteinase Inhibitory Proteins, Secretory | 2 | 2021 | 43 | 0.37 | Why? |
| Pulmonary Fibrosis | 1 | 2018 | 1068 | 0.36 | Why? |
| Forced Expiratory Volume | 1 | 2010 | 632 | 0.33 | Why? |
| Respiratory System | 1 | 2019 | 3213 | 0.32 | Why? |
| Candidiasis | 1 | 2010 | 334 | 0.30 | Why? |
| Chemotactic Factors | 1 | 2004 | 14 | 0.29 | Why? |
| Interleukin-1beta | 2 | 2020 | 992 | 0.28 | Why? |
| Elastic Tissue | 1 | 2003 | 14 | 0.27 | Why? |
| Phenotype | 4 | 2019 | 4037 | 0.27 | Why? |
| beta-Defensins | 1 | 2003 | 38 | 0.26 | Why? |
| Cathepsins | 1 | 2003 | 204 | 0.24 | Why? |
| Pneumonia | 2 | 2020 | 5652 | 0.23 | Why? |
| Sputum | 1 | 2010 | 1720 | 0.23 | Why? |
| Mutation | 3 | 2018 | 12376 | 0.22 | Why? |
| Cytokines | 2 | 2020 | 15010 | 0.21 | Why? |
| Blotting, Western | 2 | 2020 | 863 | 0.21 | Why? |
| Indenes | 1 | 2019 | 31 | 0.21 | Why? |
| Electrophoresis, Polyacrylamide Gel | 1 | 2020 | 238 | 0.21 | Why? |
| Inflammation | 3 | 2019 | 13255 | 0.21 | Why? |
| Monocytes | 3 | 2018 | 2978 | 0.20 | Why? |
| Sulfones | 1 | 2019 | 66 | 0.20 | Why? |
| Docosahexaenoic Acids | 1 | 2021 | 145 | 0.20 | Why? |
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2020 | 229 | 0.19 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.19 | Why? |
| Extracellular Space | 1 | 2018 | 26 | 0.18 | Why? |
| Heterocyclic Compounds, 4 or More Rings | 1 | 2019 | 139 | 0.18 | Why? |
| Interleukin-1alpha | 1 | 2018 | 42 | 0.18 | Why? |
| fas Receptor | 1 | 2018 | 85 | 0.18 | Why? |
| Neutrophil Infiltration | 1 | 2018 | 201 | 0.18 | Why? |
| Genetic Testing | 2 | 2018 | 395 | 0.17 | Why? |
| Bronchoalveolar Lavage Fluid | 3 | 2019 | 2309 | 0.17 | Why? |
| Chromosomes, Human, X | 1 | 2018 | 81 | 0.17 | Why? |
| Breath Tests | 1 | 2020 | 338 | 0.17 | Why? |
| Medical History Taking | 1 | 2019 | 350 | 0.16 | Why? |
| Exhalation | 1 | 2020 | 441 | 0.16 | Why? |
| Interleukin-33 | 1 | 2018 | 120 | 0.16 | Why? |
| Antimicrobial Cationic Peptides | 1 | 2018 | 159 | 0.16 | Why? |
| Phosphorylation | 1 | 2020 | 1060 | 0.16 | Why? |
| Apoptosis | 2 | 2018 | 2335 | 0.16 | Why? |
| Respiratory Function Tests | 2 | 2020 | 1755 | 0.15 | Why? |
| DNA Mutational Analysis | 1 | 2018 | 581 | 0.15 | Why? |
| Aspergillus fumigatus | 1 | 2018 | 239 | 0.15 | Why? |
| Recurrence | 2 | 2019 | 3675 | 0.15 | Why? |
| Ireland | 1 | 2020 | 1456 | 0.14 | Why? |
| Lung | 5 | 2021 | 31049 | 0.14 | Why? |
| Pseudomonas Infections | 1 | 2019 | 425 | 0.14 | Why? |
| Humans | 36 | 2021 | 930598 | 0.14 | Why? |
| MicroRNAs | 2 | 2018 | 1787 | 0.14 | Why? |
| Interleukin-1 | 1 | 2018 | 438 | 0.13 | Why? |
| Adult | 16 | 2021 | 244371 | 0.13 | Why? |
| Glycosylation | 1 | 2018 | 1255 | 0.13 | Why? |
| Biomarkers | 4 | 2021 | 23361 | 0.13 | Why? |
| Cholesterol | 1 | 2017 | 660 | 0.12 | Why? |
| Pulmonary Aspergillosis | 1 | 2018 | 408 | 0.12 | Why? |
| Cell Membrane | 1 | 2017 | 743 | 0.12 | Why? |
| Pulmonary Medicine | 1 | 2019 | 706 | 0.12 | Why? |
| Case-Control Studies | 3 | 2020 | 17671 | 0.11 | Why? |
| NF-kappa B | 1 | 2017 | 1301 | 0.10 | Why? |
| Peptide Hydrolases | 1 | 2018 | 1269 | 0.10 | Why? |
| Anti-Bacterial Agents | 2 | 2010 | 10083 | 0.10 | Why? |
| Colony Count, Microbial | 1 | 2010 | 177 | 0.10 | Why? |
| Male | 16 | 2021 | 367725 | 0.10 | Why? |
| Polymorphism, Genetic | 1 | 2017 | 1074 | 0.10 | Why? |
| Time Factors | 4 | 2020 | 31397 | 0.10 | Why? |
| Prone Position | 1 | 2021 | 1861 | 0.09 | Why? |
| Female | 14 | 2021 | 380317 | 0.09 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.09 | Why? |
| Critical Illness | 3 | 2021 | 17281 | 0.09 | Why? |
| Genotype | 2 | 2017 | 4697 | 0.09 | Why? |
| Immunologic Factors | 2 | 2021 | 4206 | 0.09 | Why? |
| Animals | 5 | 2021 | 78931 | 0.09 | Why? |
| Recovery of Function | 1 | 2018 | 2461 | 0.08 | Why? |
| Serine Proteinase Inhibitors | 2 | 2017 | 341 | 0.08 | Why? |
| Caspase 3 | 2 | 2018 | 218 | 0.08 | Why? |
| Aged | 8 | 2021 | 215776 | 0.08 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.08 | Why? |
| Autoantibodies | 1 | 2017 | 2094 | 0.08 | Why? |
| Epithelial Cells | 1 | 2018 | 3508 | 0.07 | Why? |
| Disease Progression | 2 | 2018 | 13580 | 0.07 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.07 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.07 | Why? |
| Kidney | 1 | 2019 | 3648 | 0.07 | Why? |
| Diffusion | 1 | 2003 | 73 | 0.07 | Why? |
| Lung Diseases | 1 | 2017 | 2361 | 0.07 | Why? |
| Liver Diseases | 1 | 2019 | 2698 | 0.06 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.06 | Why? |
| Mice | 2 | 2019 | 21357 | 0.06 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.06 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.06 | Why? |
| Magnetic Resonance Imaging | 1 | 2019 | 6551 | 0.06 | Why? |
| Alleles | 2 | 2019 | 1557 | 0.06 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.06 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 3832 | 0.06 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.06 | Why? |
| Asthma | 1 | 2019 | 4383 | 0.05 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 449 | 0.05 | Why? |
| Polymers | 1 | 2004 | 507 | 0.05 | Why? |
| Biomedical Research | 1 | 2019 | 5270 | 0.04 | Why? |
| Pseudomonas aeruginosa | 1 | 2003 | 652 | 0.04 | Why? |
| HL-60 Cells | 1 | 2017 | 60 | 0.04 | Why? |
| Prospective Studies | 4 | 2021 | 43301 | 0.04 | Why? |
| Calpain | 1 | 2017 | 39 | 0.04 | Why? |
| Caspase 8 | 1 | 2018 | 92 | 0.04 | Why? |
| Caveolin 1 | 1 | 2017 | 73 | 0.04 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2021 | 669 | 0.04 | Why? |
| Membrane Microdomains | 1 | 2017 | 51 | 0.04 | Why? |
| Body Mass Index | 1 | 2010 | 4306 | 0.04 | Why? |
| Cell Adhesion | 1 | 2017 | 230 | 0.04 | Why? |
| Muscles | 1 | 2017 | 152 | 0.04 | Why? |
| Caspase 7 | 1 | 2015 | 30 | 0.04 | Why? |
| Transgenes | 1 | 2017 | 227 | 0.04 | Why? |
| Dependovirus | 1 | 2017 | 272 | 0.04 | Why? |
| Capsid | 1 | 2017 | 197 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.04 | Why? |
| Young Adult | 3 | 2018 | 93724 | 0.04 | Why? |
| Tandem Mass Spectrometry | 1 | 2021 | 1031 | 0.04 | Why? |
| Endoplasmic Reticulum Stress | 1 | 2017 | 253 | 0.04 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.04 | Why? |
| Infusions, Intravenous | 1 | 2018 | 1224 | 0.03 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.03 | Why? |
| Aged, 80 and over | 3 | 2020 | 88759 | 0.03 | Why? |
| Microbial Sensitivity Tests | 1 | 2003 | 2886 | 0.03 | Why? |
| Enzyme Activation | 1 | 2015 | 425 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Up-Regulation | 1 | 2021 | 2249 | 0.03 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.03 | Why? |
| Oxidation-Reduction | 1 | 2015 | 540 | 0.03 | Why? |
| Ferritins | 1 | 2021 | 2055 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2019 | 25144 | 0.03 | Why? |
| Program Development | 1 | 2019 | 1089 | 0.03 | Why? |
| Immunophenotyping | 1 | 2017 | 1290 | 0.03 | Why? |
| Mice, Knockout | 1 | 2017 | 1815 | 0.03 | Why? |
| Europe | 2 | 2019 | 12702 | 0.03 | Why? |
| Follow-Up Studies | 1 | 2010 | 17020 | 0.03 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2017 | 698 | 0.03 | Why? |
| Advisory Committees | 1 | 2017 | 1418 | 0.03 | Why? |
| Genetic Vectors | 1 | 2017 | 1600 | 0.02 | Why? |
| Child | 1 | 2019 | 70012 | 0.02 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.02 | Why? |
| T-Lymphocyte Subsets | 1 | 2017 | 1387 | 0.02 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.02 | Why? |
| Adolescent | 1 | 2019 | 86841 | 0.02 | Why? |
| Incidence | 1 | 2010 | 25622 | 0.02 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.02 | Why? |
| Oxygen | 1 | 2021 | 3715 | 0.02 | Why? |
| Proteome | 1 | 2017 | 1812 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2015 | 3608 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Proteomics | 1 | 2017 | 2481 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2017 | 2654 | 0.02 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2017 | 2262 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 5993 | 0.02 | Why? |
| International Cooperation | 1 | 2019 | 3436 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2015 | 2483 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.02 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2017 | 4002 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2018 | 6740 | 0.02 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.02 | Why? |
| Cell Line | 1 | 2018 | 12040 | 0.01 | Why? |
| Societies, Medical | 1 | 2017 | 6907 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Registries | 1 | 2019 | 12327 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.01 | Why? |
McElvaney's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(212)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(75)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_